Neuroblastoma: Current Imaging and Therapeutics
Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 3
Abstract
Neuroblastoma is the most common solid abdominal tumor in children under the age of 2 years and accounts for approximately 15% of childhood mortality due to cancer. Its clinical behavior can vary from spontaneous regression to rapid fatal progression and anywhere in between (e.g. differentiation into benign tumors). Unfortunately, 50% of patients already have metastases at presentation. This marked clinical variability and often advanced presentation at time of diagnosis must be addressed with improved imaging and new treatments, particularly through focus on expanded drug development. Current treatment regimens (surgical resection, chemotherapy, and radiotherapy) have proven to be inadequate for treating advanced disease and frequently cause severe side effects that make them intolerable for many children. Promising new therapies include anti-adhesion therapy and immunotherapy, which uses antibodies to trigger a patient’s own immune system to destroy neuroblastoma cells. Of particular interest in the realm of anti-adhesion is attenuation of NF-κB over-activation. Increased NF-κB activity is thought to play a role in the development of tumor resistance to chemotherapeutic agents and radiation. Therefore, novel drugs to attenuate NF-kB activity could revolutionize treatment by increasing overall treatment effectiveness and allowing for reduced drug and radiation doses for dose-sensitive patients.
Authors and Affiliations
Xudong Huang, Ami K. Patel, Krupa K. Patel, Eva-Maria Ratai
Keywords
Related Articles
- EP ID EP242956
- DOI 10.9734/JCTI/2015/16165
- Views 106
- Downloads 0
Evaluation of Efficacy of Gefinitib in Comparison with Chemotherapy in Patients with Non-Small Cell Lung Carcinoma from India
Aim: Tyrosine kinase inhibitors (TKIs) are a new class of drugs that are proven to be more efficacious than chemotherapy in certain cancers including lung cancer. However, the efficacy of TKIs may vary in different globa...
Circulating Prostate Gland Cells in Benign Prostatic Hyperplasia and Adenocarcinoma in Patients of African Heritage: Diagnosis by Liquid Biopsy: Preliminary Results
Background: Benign prostatic hyperplasia and adenocarcinoma are two major urological conditions of the human prostate gland. Benign prostatic hyperplasia is due to increase in stromal cells and adenocarcinoma of the pros...
Prognostic Value of KRAS Mutations in Codons 12 and 13 in South Egyptian Colorectal Cancer Patients
Aims: The aim of the study was to assess the frequency of Kirsten rat sarcoma viral oncogene homolog (KRAS) gene mutation, perform clinicopathologic characterization of KRAS mutated colorectal cancer (CRC), evaluation of...
Sex Hormones, Oestrogen Receptor, Progesterone Receptor and Human Epithelial Receptor 2 Expressions in Pre and Postmenopausal Sub-Saharan African Women with Breast Cancer
Aim: This study was carried out to determine the serum levels of sex hormones and gonadotropins as well as the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epithelial receptor 2 (HER 2) in...
Collision Tumor at the Gastroesophageal Junction; Coexistence of Basaloid Squamous Cell Carcinoma and Small Cell Neuroendocrine Carcinoma
Basaloid squamous cell carcinoma (BSC) is a poorly differentiated and rare variant of squamous cell carcinoma. It is frequently seen in the upper respiratory and gastrointestinal systems. Neuroendocrine tumors originate...